A new US study suggests that weight-loss medications like Wegovy and Ozempic may have rare but serious side effects, including abdominal paralysis, linked to GLP-1 agonist drugs.
Posted from: this blog via Microsoft Power Automate.
A new US study suggests that weight-loss medications like Wegovy and Ozempic may have rare but serious side effects, including abdominal paralysis, linked to GLP-1 agonist drugs.
Posted from: this blog via Microsoft Power Automate.